Notification of Issuance of Equity Securities

Summary by AI BETAClose X

Jardine Matheson Holdings Limited has issued and admitted 1,994,248 ordinary shares under its Scrip Dividend Scheme for the 2025 final dividend, bringing the total number of ordinary shares in issue to 294,843,676. These newly issued shares, with a nominal value of US cents 25 each, were issued on 13 May 2026 and admitted to trading on the London Stock Exchange's Main Market on 14 May 2026, and are fully fungible with existing ordinary shares.

Disclaimer*

Jardine Matheson Hldgs Ltd
18 May 2026
 

JARDINE MATHESON HOLDINGS LIMITED (the 'Company')

NOTIFICATION OF ISSUANCE OF EQUITY SECURITIES

The Company notifies the market that the Company's ordinary shares have been issued and allotted under the Company's Scrip Dividend Scheme in respect of 2025 final dividend. This notification is made in accordance with the Financial Conduct Authority's PRM Admission to Trading on a Regulated Market PRM 1.6.4.

 

1

Details of the issuer

a)

Name

Jardine Matheson Holdings Limited

b)

LEI

2138009KENVUNWOLPK41

2

Details of the transferable securities issued and admitted to trading

a)

Name, type and identification code

Jardine Matheson Holdings Limited

Ordinary shares of US cents 25 each

BMG507361001

b)

Regulated market

London Stock Exchange - Main Market

c)

Number of further securities issued and admitted

1,994,248 ordinary shares

 

d)

Total number of securities admitted following issuance

294,843,676 ordinary shares

e)

Fungibility

Fully fungible with existing ordinary shares

3

Issue and admission details

a)

Dates of issuance and admission

Issued on 13 May 2026 and admitted on 14 May 2026

b)

Prospectus information

Prospectus: N/A

Supplementary: N/A

Company's website: www.jardines.com

 

Sean Ward
Company Secretary
Jardine Matheson Holdings Limited

18 May 2026

www.jardines.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings